Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with ...
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic ...
Governments and airlines are backing eVTOLs with policy and investments, and designs for their infrastructure are starting to ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the first European participants have been randomized in ...
The past few months have seen announcements of prototype electric vehicles that don’t use inverters to produce three-phase ...
Cryptopolitan on MSN
UK’s Wayve starts testing self-driving features in Nissan vehicles
British startup Wayve has begun on-road trials in Japan with Nissan and is in talks with Nvidia over a possible $500 million ...
Hyundai Motor Company just held its first CEO Investor Day outside South Korea and unveiled its most ambitious growth ...
In a now-completed clinical trial, the stem cell therapy Neuronata-R was found to benefit ALS patients with slower disease ...
The denial sets back a drug Scholar Rock hopes to become part of a new standard of care for spinal muscular atrophy, ...
Interesting Engineering on MSN
YouTuber makes full-scale DeLorean fly for real in jaw-dropping test video
A YouTuber has made a full-scale DeLorean prop fly. From carbon fiber frames to retracting wheels, the legendary car just lifted off.
The growth of the Robo Advisor Market is driven by the increasing adoption of digital wealth management platforms, rising ...
Nissan showcases its next-gen ProPILOT in Tokyo, aiming for smarter city driving and an autonomous ride-share launch by 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback